StockData
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX) income statement

FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30
$1.79−0.04 (-2.19%)

Close on Nov 18, 2026Market cap $106.30MP/E –Yield –

See a number that looks wrong?